Compare BIO & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | MNDY |
|---|---|---|
| Founded | 1952 | 2012 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 7.4B |
| IPO Year | N/A | 2021 |
| Metric | BIO | MNDY |
|---|---|---|
| Price | $322.33 | $132.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 24 |
| Target Price | ★ $358.50 | $265.42 |
| AVG Volume (30 Days) | 184.0K | ★ 1.2M |
| Earning Date | 02-12-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 192.87 |
| EPS | N/A | ★ 1.23 |
| Revenue | ★ $2,557,500,000.00 | $1,166,095,000.00 |
| Revenue This Year | $1.62 | $28.81 |
| Revenue Next Year | $2.26 | $21.41 |
| P/E Ratio | ★ N/A | $106.31 |
| Revenue Growth | N/A | ★ 28.62 |
| 52 Week Low | $211.43 | $129.99 |
| 52 Week High | $373.69 | $342.64 |
| Indicator | BIO | MNDY |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 32.72 |
| Support Level | $316.57 | $129.77 |
| Resistance Level | $328.56 | $147.39 |
| Average True Range (ATR) | 8.27 | 5.51 |
| MACD | 1.43 | -0.86 |
| Stochastic Oscillator | 78.70 | 14.32 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.